STOCK TITAN
  1. Home
  2. News
  3. ATRI

Atrion Corp. - ATRI STOCK NEWS

Welcome to our dedicated news page for Atrion (Ticker: ATRI), a resource for investors and traders seeking the latest updates and insights on Atrion.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Atrion's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Atrion's position in the market.

News
Atrion Reports Fourth Quarter And Full Year 2023 Results
Rhea-AI Summary
Atrion Corporation (NASDAQ: ATRI) reported its Q4 2023 results with revenues of $43.6 million, up $729 thousand, operating income of $6.7 million, down $2.1 million, and net income of $6.4 million, down $1.9 million. Full year 2023 revenues were $169.3 million, down $14.2 million, with net income at $19.4 million, down $15.6 million. The company faced challenges due to global supply chain issues impacting production and sales.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
earnings
-
News
Atrion Corporation Declares Quarterly Cash Dividend
Rhea-AI Summary
Atrion Corporation (ATRI) declares a quarterly dividend of $2.20 per share. The dividend will be payable on March 29, 2024, to stockholders of record on March 15, 2024. Atrion focuses on developing and manufacturing products for medical applications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
dividends
-
News
Atrion Corporation Declares Quarterly Cash Dividend
Rhea-AI Summary
Atrion Corporation (NASDAQ: ATRI) Declares Quarterly Dividend of $2.20 per Share. Atrion Corporation announced the declaration of a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. Payable on December 15, 2023, to stockholders of record at the close of business on December 1, 2023. Atrion Corporation develops and manufactures products primarily for medical applications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.55%
Tags
dividends
News
Atrion Reports Third Quarter 2023 Results
Rhea-AI Summary
Atrion Corporation (NASDAQ: ATRI) announced third-quarter results, reporting a decrease in revenues, operating income, and net income compared to the same period in 2022. Diluted earnings per share were also down. The President and CEO attributed the decrease to OEM sales being negatively impacted by customers deferring orders due to supply chain shortages in 2022 and the inability to obtain sufficient components to meet demand for MPS 3 consoles. Sequentially, revenues for 2023 quarters were down 15% in Q1, 10% in Q2, and 6% in Q3 compared to the same periods in 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.63%
Tags
earnings
-
News
Atrion Corporation Announces Election of New Director
Rhea-AI Summary
Atrion Corporation appoints Jeannette Bankes as a director, bringing extensive experience in medical device and pharmaceutical companies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags
management
-
News
Atrion Corporation Increases Quarterly Cash Dividend
Rhea-AI Summary
Atrion Corporation increases quarterly cash dividend from $2.15 to $2.20 per share.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.12%
Tags
dividends
News
Atrion Reports Second Quarter 2023 Results
Rhea-AI Summary
Atrion Corporation reported second-quarter revenues of $43.8 million, a decrease of 10% compared to the same period in 2022. Operating income was $7.4 million, down $3.7 million, and net income was $6.6 million, down $2.8 million. Diluted earnings per share for Q2 2023 were $3.73. The company's CEO mentioned that the decline in results was due to reduced customer inventories. Atrion is implementing initiatives to improve performance, including facility expansion and resolving supply chain shortages. Cash and investments totaled $15.6 million at the end of June 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
earnings
-
News
Atrion Corporation Declares Quarterly Cash Dividend
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.63%
Tags
dividends
-
News
Atrion Reports First Quarter 2023 Results
Rhea-AI Summary
Atrion Corporation reported disappointing results for the first quarter of 2023. Revenues were $40.0 million, down 15% from the same period last year. Operating income was $4.5 million, a decrease of 56%, and net income was $3.5 million, down 59%. Diluted earnings per share were $1.98 compared to $4.71 in Q1 2022. The company attributes the decline to delayed deliveries from customers due to concerns about a global economic slowdown. Atrion Corporation has cash and investments totaling $26.3 million and expects additional requests to delay deliveries.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.29%
Tags
earnings
News
Atrion Reports Fourth Quarter and Full Year 2022 Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.96%
Tags
none
Stock ATRI logo
Atrion Corp.

Nasdaq:ATRI

ATRI Rankings

#2652 Ranked by Market Cap
#4445 Ranked by Stock Gains
#1389 Ranked by Dividends

ATRI Stock Data

720.00M
1.33M
22.86%
66.56%
5.55%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Allentown

About ATRI

atrion corp is a medical device company located in 527 plymouth rd, plymouth, pennsylvania, united states.